Invention Grant
- Patent Title: Biomarkers for cholangiocellular carcinoma (CCC)
-
Application No.: US14916583Application Date: 2014-09-08
-
Publication No.: US10429391B2Publication Date: 2019-10-01
- Inventor: Barbara Sitek , Helmut E. Meyer , Dominik Megger , Thilo Bracht , Juliet Padden , Hideo A. Baba , Jörg F. Schlaak , Frank Weber
- Applicant: LEIBNIZ-INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN—ISAS—E.V.
- Applicant Address: DE Dortmund
- Assignee: LEIBNIZ-INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN—ISAS—E.V.
- Current Assignee: LEIBNIZ-INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN—ISAS—E.V.
- Current Assignee Address: DE Dortmund
- Agency: Drinker Biddle & Reath LLP
- Priority: EP13183452 20130906
- International Application: PCT/EP2014/069115 WO 20140908
- International Announcement: WO2015/032954 WO 20150312
- Main IPC: G01N31/00
- IPC: G01N31/00 ; G01N33/574 ; G01N33/68 ; G01N33/53
Abstract:
The invention relates to a method for identifying specific marker proteins (biomarkers) for cholangiocellular carcinoma (CCC), the biomarkers for CCC identified by the method and the use thereof, in particular for diagnosis, surveillance and treatment. The invention further relates to a diagnostic device comprising the biomarkers for CCC and a screening assay wherein these biomarkers for CCC are used to identify novel pharmaceutical compounds for treatment of CCC.
Public/Granted literature
- US20160195537A1 BIOMARKERS FOR CHOLANGIOCELLULAR CARCINOMA (CCC) Public/Granted day:2016-07-07
Information query
